Latest News

CDC, SAMHSA commit $1.8 billion to combat opioid crisis


 

More financial reinforcements are arriving in the battle against the opioid crisis, with the Trump administration promising more than $1.8 billion in new funds to help states address the crisis.

CDC News icon

Speaking at a Sept. 4 press conference announcing the funding, President Donald Trump said the money will be used “to increase access to medication and medication-assisted treatment and mental health resources, which are critical for ending homelessness and getting people the help they deserve.” The president added that the grants also will help state and local governments obtain high-quality, comprehensive data.

The Centers for Disease Control and Prevention will provide more than $900 million in new funding over the next 3 years to “advance the understanding of the opioid overdose epidemic and to scale-up prevention and response activities,” the Department of Health & Human Services said in a statement announcing the funding.

“This money will help states and local communities track overdose data and develop strategies that save lives,” HHS Secretary Alex Azar said during the press conference.

He noted that, when the Trump administration began, overdose data were published with a 12-month lag. That lag has since shortened to 6 months. One of the goals with the new funding is to bring data publishing as close to real time as possible.

Separately, the Substance Abuse and Mental Health Services Administration awarded $932 million to all 50 states as part of its State Opioid Response grants, which “provide flexible funding to state governments to support prevention, treatment, and recovery services in the ways that meet the needs of their state,” according to the HHS statement.

That flexibility “can mean everything from expanding the use of medication-assisted treatment in criminal justice settings or in rural areas via telemedicine, to youth-focused community-based prevention efforts,” Secretary Azar explained. The funds can also support employment coaching and naloxone distribution, he added.

Recommended Reading

Nicotine replacement therapy beats varenicline for smokers with OUD
Clinician Reviews
Vaping among teens increased significantly from 2017 to 2018
Clinician Reviews
Opioid exposure leads to poor perinatal and postnatal outcomes
Clinician Reviews
Smoking-cessation attempts changed little over 7-year span
Clinician Reviews
Pharmacist stigma a barrier to rural buprenorphine access
Clinician Reviews
CDC finds that too little naloxone is dispensed
Clinician Reviews
USPSTF draft guidance calls for drug use screening
Clinician Reviews
FDA takes another swing at updating cigarette pack warnings
Clinician Reviews
Opioid Epidemic
Clinician Reviews
First death from severe lung illness associated with vaping reported in Illinois
Clinician Reviews